| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0007 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0008 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0008 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0008 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.17 | 0.0009 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.15 | 0.001 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |